Ashley Mastrangelo, DPM
Foot & Ankle Surgery · Pawtucket, RINPI 1013323419
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (50.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Arthrex at 51.4% of the total. Reporting peaked in 2022 at $3,362 and has fallen 98.8% since, to $41 in 2025.
Across 43 payments — averaging $159.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Kairos Surgical Inc$3K
- Stryker$583
- Treace Medical Concepts, Inc.$140
- Solventum Corporation$24
- Smith+Nephew$15
What the payments were for
- Travel & lodging$2,75640%
- Food & beverage$6339%
- Education$3,47851%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 28 | $3,531 |
| Kairos Surgical Inc | 6 | $2,575 |
| Stryker | 5 | $583 |
| Treace Medical Concepts, Inc. | 2 | $140 |
| Solventum Corporation | 1 | $24 |
| Smith+Nephew | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$532
- Lapiplasty System$123
How this compares
$6,867 in reported general payments places this provider in the 75th percentile of 58 foot & ankle surgery providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 18 | $515 |
| Methylprednisolone | 30 | $218 |
| Cephalexin | 28 | $128 |
| Gabapentin | 20 | $49 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Pawtucket
- Matthew LawrencePawtucket$38K
- Michal SzparaPawtucket$37K
- James AppletonPawtucket$10K
- Aaron ShemenskiPawtucket$7K
- Nicole CurreriPawtucket$2K
- Melvin ManciniPawtucket$586
- Christopher DigiovanniProvidence$665K
- Anthony MechrefeWarwick$92K
- Douglas GlodEast Providence$74K
- Michael ReuterBristol$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.